Primary hyperaldosteronism is one of the most frequent causes of symptomatic arterial hypertension. This case illustrates special features of the course and diagnostics of PHA. Early diagnosis will rid patient from hypertension or will make its course milder which will let minimize the risk of development of complications.

1. Протащик Д. В., Ворохобина Н. В., Шафигуллина З. Р. Клинические особенности первичного гиперальдостеронизма // Вестн. СевероЗападного гос. мед. ун-та им. И. И. Мечникова. 2013. № 4. С. 114–119.

2. Fardella CE, Mosso L, Gomez-Sanchez C et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000; 85: 1863–7.

3. Lim PO, Dow E, Brennan G et al. High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 2000; 14: 311–5.

4. Loh KC, Koay ES, Khaw MC et al. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000; 85: 2854–9.

5. Mulatero P, Stowasser M, Loh KC et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clinic Endocrinol Metabo 2004; 89: 1045–50.

6. Mosso L, Carvajal C, Gonzalez A et al. Primary aldosteronism and hypertensive disease. Hypertension 2003; 42: 161–5.

7. Schwartz GL, Turner ST. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem 2005; 51: 386–94.

8. Hannemann A, Bidlingmaier M, Friedrich N et al. Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. Eur J Endocrinol 2012; 167: 7–15.

9. Rossi GP, Bernini G, Caliumi C et al. A prospective study of the prevalence of primary aldosteronism in 1.125 hypertensive patients. J Am Coll Cardiol 2006; 48: 2293–300.

10. Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, Papadopoulos N, Vogiatzis K, Zamboulis C. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet. 2008;371(9628):1921–6. doi: 10.1016/S0140-6736(08)60834-X.

11. Milliez P., Girerd X., Plouin P. F., Blacher J. et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism // J. Am. Coll. Cardiol. 2005. Vol. 45. P. 1243–1248.

12. Бельцевич Д. Г. Клинические рекомендации по материалам консенсуса по первичному гиперальдостеронизму / пер. Д. Г. Бельцевич // Эндокринная хирургия. 2008. № 2. С. 6–30.

13. G. A. Melnichenko et al. Первичный гиперальдостеронизм: диагностика и лечение. Новый взгляд на проблему. По материалам Проекта клинических рекомендаций Российской ассоциации эндокринологов по диагностике и лечению первичного гиперальдостеронизма/ Consilium Medicum. 2017; 19 (4): 75–85.